What is the recommended dosage of oxycodone (OxyContin) for a patient transitioning from hydromorphone (Dilaudid) 4 mg?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Converting Hydromorphone 4 mg to Oxycodone

When transitioning from hydromorphone 4 mg to oxycodone, the recommended dosage is 20 mg of oral oxycodone daily, which should be reduced by 25-50% to 10-15 mg daily to account for incomplete cross-tolerance. 1

Conversion Process

  • Calculate the total daily hydromorphone dose (4 mg in this case) 2, 1
  • Apply the conversion ratio: 4 mg oral hydromorphone is equivalent to 20 mg oral oxycodone 1, 3
  • Reduce the calculated equianalgesic dose by 25-50% to account for incomplete cross-tolerance, resulting in 10-15 mg oxycodone daily 2, 1
  • Divide the daily oxycodone dose by the number of doses per day (e.g., for 4 doses per day, 10-15 mg daily would equal 2.5-3.75 mg per dose) 1

Dosing Considerations

  • If pain was effectively controlled with hydromorphone, use the reduced dose (10-15 mg daily) 2
  • If pain was poorly controlled with hydromorphone, consider using 100% of the equianalgesic dose (20 mg daily) or even increasing by 25% (25 mg daily) 2, 1
  • No washout period is needed when converting between these two pure opioid agonists 1

Breakthrough Pain Management

  • Provide short-acting oxycodone rescue doses during the transition period 1
  • Breakthrough doses typically should be 10-15% of the total daily dose 1
  • Monitor the patient's response and adjust the dose accordingly 2

Important Clinical Considerations

  • Patient variability means suggested doses are approximate and clinical judgment must be used to titrate to the desired response 2
  • Consider patient-specific factors such as age, renal/hepatic function, and comorbidities when determining the final dose 1
  • Research shows that hydromorphone and oxycodone have similar efficacy and safety profiles when appropriately dosed 4, 5
  • For extended-release formulations, ensure the total daily dose is appropriately calculated before converting to the extended-release schedule 6

Potential Pitfalls

  • Avoid using fixed conversion ratios without clinical judgment 1
  • Be cautious of underdosing or overdosing during the transition period 1
  • Monitor for adverse effects such as nausea, constipation, somnolence, and dizziness, which are common with both medications 4, 5
  • Ensure the patient understands the dosing schedule and importance of taking medications as prescribed 2

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.